Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clobetasol 0.05% ointment
1304000G0AABABA
|
Clobetasol propionate | Clobetasol propionate | Skin | 78,481 |
|
Clobetasol 0.05% cream
1304000G0AAAAAA
|
Clobetasol propionate | Clobetasol propionate | Skin | 58,058 |
|
Clobetasol 0.05% scalp application
1304000G0AABBBB
|
Clobetasol propionate | Clobetasol propionate | Skin | 12,947 |
|
Clobetasol 500micrograms/g shampoo
1304000G0AACDCD
|
Clobetasol propionate | Clobetasol propionate | Skin | 5,081 |
|
Clobetasol 500microg/Neomycin 5mg/Nystatin 100,000unit/g crm
1304000G0AACACA
|
Clobetasol propionate | Clobetasol propionate | Skin | 1,487 |
|
Clobetasol 500microg/Neomycin 5mg/Nystatin 100,000u/g oint
1304000G0AACBCB
|
Clobetasol propionate | Clobetasol propionate | Skin | 1,153 |
|
Clobetasol 500micrograms/g foam
1304000G0AACCCC
|
Clobetasol propionate | Clobetasol propionate | Skin | 67 |
|
Clobet .05% oint 50%/Propylene glycol 48%/Salic acid 2% oint
1304000G0AADMDM
|
Clobetasol propionate | Clobetasol propionate | Skin | 2 |
|
Clobetasol 0.05% ointment 20% in White soft paraffin
1304000G0AACPCP
|
Clobetasol propionate | Clobetasol propionate | Skin | 2 |
|
Clobet .05% crm 25%/Propylene glycol 40% in Gen Unguen M crm
1304000G0AADPDP
|
Clobetasol propionate | Clobetasol propionate | Skin | 1 |
|
Clobetasol 0.05% ointment 50% in White soft paraffin
1304000G0AACGCG
|
Clobetasol propionate | Clobetasol propionate | Skin | 1 |
|
Propylene glycol 40% in Clobetasol 0.05% ointment
1304000G0AADBDB
|
Clobetasol propionate | Clobetasol propionate | Skin | 1 |
|
Salicylic acid 5% in Clobetasol 0.05% cream
1304000G0AADCDC
|
Clobetasol propionate | Clobetasol propionate | Skin | 1 |
|
Clobetasol 0.05% cream 10% in Aqueous cream
1304000G0AADIDI
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 10% in Generic Unguentum M cream
1304000G0AACZCZ
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 25% in Cetomacrogol cream (Formula A)
1304000G0AADGDG
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 25% in White soft paraffin
1304000G0AACQCQ
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 30% in Aqueous cream
1304000G0AACXCX
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 50% in Generic Unguentum M cream
1304000G0AADADA
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 50% in White soft paraffin
1304000G0AACRCR
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% crm 25%/Propylene glycol 40% in Aqueous crm
1304000G0AADKDK
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% oint 20% in Cetomacrogol crm (Formula A)
1304000G0AADHDH
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% oint 25%/Dithranol 0.05% in WSP
1304000G0AADFDF
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% ointment 10% in Generic Unguentum M cream
1304000G0AACMCM
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% ointment 10% in White soft paraffin
1304000G0AACJCJ
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.